|
 |
Vaccine Technology II
June 1-6, 2008 - Algarve, Portugal
| Editors: |
Barry C. Buckland, Merck & Co., Inc.
John G. Auniņš, Merck & Co., Inc.
Paula Marques Alves, ITQB/IBET
Kathrin U. Jansen, Wyeth Vaccine Research |
The articles for these proceedings are not peer-reviewed.
|
<Previous article
|
Next article>
|
VEEV Replicon-Based Vaccines Used in Heterologous Prime Boost Strategies Induce Lifelong Protection Against Prostate Cancer and Therapy of Cervical Cancer in Mice and Robust Cell-Mediated Immunity in Rhesus macaques
W. Martin Kast, University of Southern California
W. Martin Kast, "VEEV Replicon-Based Vaccines Used in Heterologous Prime Boost Strategies Induce Lifelong Protection Against Prostate Cancer and Therapy of Cervical Cancer in Mice and Robust Cell-Mediated Immunity in Rhesus macaques" in "Vaccine Technology II", Barry C. Buckland, Merck & Co., Inc.
John G. Auniņš, Merck & Co., Inc.
Paula Marques Alves, ITQB/IBET
Kathrin U. Jansen, Wyeth Vaccine Research
Eds, ECI
Symposium Series, Volume P09 (2008). http://services.bepress.com/eci/vaccine/4
|
|
|
|
 |
|
|
|
|
|
|
|
